Trump Administration Halts Acquisition of Fetal Tissue for Research

Two NIH-run labs are affected, including one that seeks to cure HIV.

Written byAshley P. Taylor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In September, President Donald Trump’s administration ordered National Institutes of Health labs to stop acquiring human fetal tissue for research, ScienceInsider reports. Agency officials say the order applies to intramural research and not to that of scientists at non-NIH institutions receiving agency grants or contracts.

This move has affected two labs, NIH officials tell ScienceInsider: one run by the National Eye Institute, which uses fetal retinal tissue to study eye diseases, and another at a National Institute of Allergy and Infectious Diseases facility in Montana, which uses humanized mice generated using fetal tissue to study HIV infection.

“We were all poised to go and then the bombshell was dropped,” Warner Greene, director of the Gladstone Center for HIV Cure Research in San Francisco, California, who was collaborating with the Montana lab, tells ScienceInsider. The two groups were about to start experiments in humanized mice testing an antibody-based treatment to prevent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies